Advances in PEGylation of important biotech molecules: delivery aspects - Wikidata - wikimedia - TriplyDB

Advances in PEGylation of important biotech molecules: delivery aspects

Advances in PEGylation of important biotech molecules: delivery aspects

http://www.wikidata.org/entity/Q28277255

about

PEGylation of Interferon-β-1a Bioorthogonal chemistry: fishing for selectivity in a sea of functionality PEGylated Adenoviruses: From Mice to Monkeys Evolution of contrast agents for ultrasound imaging and ultrasound-mediated drug delivery.Future of coagulation factor replacement therapy Cys34-PEGylated Human Serum Albumin for Drug Binding and Delivery Nano delivers big: designing molecular missiles for cancer therapeutics.Chemical modification with high molecular weight polyethylene glycol reduces transduction of hepatocytes and increases efficacy of intravenously delivered oncolytic adenovirus Amphiphilic nanoparticles repress macrophage atherogenesis: novel core/shell designs for scavenger receptor targeting and down-regulation.Exploring the efficiency of gallic acid-based dendrimers and their block copolymers with PEG as gene carriers.Site specific discrete PEGylation of (124)I-labeled mCC49 Fab' fragments improves tumor MicroPET/CT imaging in mice.Species differences in the pharmacology and toxicology of PEGylated helper-dependent adenovirus In vivo anti-tumor activity of polypeptide HM-3 modified by different polyethylene glycols (PEG).Distribution and clearance of PEG-single-walled carbon nanotube cancer drug delivery vehicles in mice Tumor vascular targeted delivery of polymer-conjugated adenovirus vector for cancer gene therapy Enhanced antitumor immunity of nanoliposome-encapsulated heat shock protein 70 peptide complex derived from dendritic tumor fusion cells.Linearized oncolytic adenoviral plasmid DNA delivered by bioreducible polymers.Electrospinning of PEGylated polyamidoamine dendrimer fibers.The effect of nanoparticle polyethylene glycol surface density on ligand-directed tumor targeting studied in vivo by dual modality imaging.Engineering the lipid layer of lipid-PLGA hybrid nanoparticles for enhanced in vitro cellular uptake and improved stability.Nitric oxide-releasing silica nanoparticle inhibition of ovarian cancer cell growth.Scratching the Surface: Resurfacing Proteins to Endow New Properties and Function.Engineered silica nanoparticles act as adjuvants to enhance allergic airway disease in mice.Using anti-poly(ethylene glycol) bioparticles for the quantitation of PEGylated nanoparticles Enhancement of the efficacy of therapeutic proteins by formulation with PEGylated liposomes; a case of FVIII, FVIIa and G-CSF.Product development issues for PEGylated proteins.Drug delivery using multifunctional dendrimers and hyperbranched polymers.Design of biocompatible dendrimers for cancer diagnosis and therapy: current status and future perspectives.Overcoming in vivo barriers to targeted nanodelivery.Integrin targeted delivery of gene therapeutics Production methodologies of polymeric and hydrogel particles for drug delivery applications.Advances and trends in the design, analysis, and characterization of polymer-protein conjugates for "PEGylaided" bioprocesses.Medicinal chemistry based approaches and nanotechnology-based systems to improve CNS drug targeting and delivery.The oral delivery of peptides and proteins: established versus recently patented approaches.Recent developments in protein and peptide parenteral delivery approaches.Novel products for haemostasis - current status.Formulation strategies to improve oral peptide delivery.Advances in lipid-based drug delivery: enhancing efficiency for hydrophobic drugs.Partially PEGylated PAMAM dendrimers as solubility enhancers of Silybin.The effects of oil-in-water nanoemulsion polyethylene glycol surface density on intracellular stability, pharmacokinetics, and biodistribution in tumor bearing mice.

P2860

Q22241420-ABDA2AEE-D3EF-4511-8DE8-F744DA484B80 Q24629024-9BDA3CCC-C4E3-4D3A-B018-CE964DAF29AA Q24635276-C869818C-0127-490E-88AC-0679718931F4 Q26781564-B5766446-D389-4DE0-BE59-72BA8C2D6823 Q26820824-AAAFEF46-4E07-49DC-A030-1A77A4E9DD38 Q27301475-7A4F02E0-1698-4126-BEC4-F2B349CBD6D1 Q30470080-B43D554F-CADA-442D-810B-5276DACC849F Q33690982-6670056C-5248-41F4-8A33-17E31A32CB04 Q34089117-1184576F-2613-43E1-A3A2-1BE68277CF87 Q34343876-9EC8BEDE-CAB6-40F4-9D13-00B89DD3B894 Q34555580-B878253A-78BA-48A6-96E4-4882830871C0 Q34975214-11FC2877-F742-4A72-B427-56304403B8D6 Q35079289-65E3819D-98B7-419A-8CF3-66407CBB6D63 Q35219950-CDEC9C8A-D216-47C3-9EB4-A547A6B6A5B9 Q35238254-A4D8DBEA-81A1-4129-B1D5-77563F714A19 Q35605763-C8488476-AC50-4E58-AB36-9117FD97640F Q35869766-D88069A4-6422-430C-B521-21931975586B Q36003877-8D0917AA-F4BC-40AC-8B4B-4EB65A10EFB3 Q36075868-709DBBDC-A9B9-4A01-AFEF-717F57E026FD Q36289194-F81D5DBC-BACC-4453-8604-90437BD681E5 Q36602038-C8D21645-EAD1-4E49-BA9E-ED77C18F8A24 Q36945870-B567CDFF-E3C1-46E2-87ED-2BE558088355 Q37059794-D8F53EA2-F4AA-4694-A14C-3D36158D9AFE Q37518724-C0FE4FCD-C116-4943-B064-EB437C3983E9 Q37679949-30E3A838-EC6A-4C6C-8918-0807C6FFA8CB Q37790702-4A4A4E79-11F5-43A1-9171-BE2A1A40F22F Q37809880-A30424D2-574B-4F06-B85E-B7CCE1ADCED1 Q37834336-F5F38E6F-AFB0-4820-A9F5-6350045C3D87 Q37871580-C612902D-A3E9-480F-90E7-CBC11492EB0B Q37872613-92108539-6D97-4BE1-96A6-7D3E116D6BE0 Q37976414-27D5DDD8-2354-467A-8DDB-5C7151A49913 Q37988373-C4024D22-7260-42EC-8BCE-14BEA5C9D7A7 Q37995554-E1C56FA4-FD26-4EB4-85DC-00ED55B2DAC2 Q38162959-ACAEEBE9-1F6A-4232-A4D3-B390C1C65F50 Q38193174-4CE49F79-9061-4BC9-802D-CCB217E8238F Q38206849-ED493A85-0F4B-466E-BB63-7AE410FDB344 Q38226675-AD8BC152-24FC-4F30-B9C9-6D5C1E5BCA9E Q38406190-2FB99FCA-1DF5-472D-8A6C-71A0981F2C4C Q38736230-1AA3C049-DB22-4028-B004-6575368F9354 Q38944782-E9D4B711-B0EB-4FCA-BE01-F65884FE5E0E

P2860

Advances in PEGylation of important biotech molecules: delivery aspects

http://www.wikidata.org/entity/Q28277255

description

2008 nî lūn-bûn

@nan

2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Advances in PEGylation of important biotech molecules: delivery aspects

@ast

Advances in PEGylation of important biotech molecules: delivery aspects

@en

Advances in PEGylation of important biotech molecules: delivery aspects

@nl

type

label

Advances in PEGylation of important biotech molecules: delivery aspects

@ast

Advances in PEGylation of important biotech molecules: delivery aspects

@en

Advances in PEGylation of important biotech molecules: delivery aspects

@nl

prefLabel

Advances in PEGylation of important biotech molecules: delivery aspects

@ast

Advances in PEGylation of important biotech molecules: delivery aspects

@en

Advances in PEGylation of important biotech molecules: delivery aspects

@nl

P1433

Q28277255-91E18D31-04E2-487A-A8AE-53400D58B0A5

P1476

Q28277255-798D55AC-CF94-49AE-8DBD-F8D1A12B626D

P2093

Q28277255-6C962B39-9725-4C4F-8112-9D91DC45C885

Q28277255-FE6C3AA4-8651-45DE-BA00-C3D79783B49F

P2860

Q28277255-01BF6AB9-9F13-4B26-B745-A74FAB6E826E

Q28277255-06C7849E-FF21-44BB-8D13-0DBC333DB890

Q28277255-07B873A0-9F46-40C7-B270-92A1E99ABE49

Q28277255-0B1F49D3-236E-4B58-8DCC-5DBC576C953F

Q28277255-1076F9A6-908D-4CA9-A7AD-83A002B7CE1F

Q28277255-12825E49-19EB-434A-B51A-BD7194997B8F

Q28277255-145CFA82-8C5D-4778-A560-B311F0DD32BC

Q28277255-1BA8AA17-5E02-4C00-A5EF-6AC154A648AA

Q28277255-2069013D-D229-4B04-8A3A-FFFE8BC0FDA5

Q28277255-230C9713-C1D9-4F43-ACE4-32A822FF91BF

P304

Q28277255-B056DA74-E705-4DED-AA0D-137A521D36CF

P31

Q28277255-EB77575A-55DD-4CE7-A1F9-A69128552DE5

P356

Q28277255-D252FAD7-D398-41E0-9EB7-A0137E6057E6

P407

Q28277255-3055E19A-7599-4FC4-8364-3118DE3AB062

P433

Q28277255-7A337AF4-80CE-4B5E-9FA1-8CF7B1306FEE

P478

Q28277255-E421B214-E2B0-494A-BF5A-62A710CC281A

P50

Q28277255-2C2B7D24-7BD7-4124-B2D2-1B334873C175

Q28277255-8C80DC64-5A08-43AB-98B2-E3DB79936DF0

Q28277255-EF8902CB-389E-4BFE-A17F-7A6D1C64A0C2

P577

Q28277255-4477F53F-B099-4A5C-95C0-091A04F638D8

P5875

Q28277255-BF023045-4114-4EF0-A09C-A349EFA760BF

P698

Q28277255-49B1ABE3-D7AC-4A72-AF8D-A5FE3E4C8ED2

P356

17425247.5.4.371

P1433

Expert Opinion on Drug Delivery

P1476

Advances in PEGylation of important biotech molecules: delivery aspects

@en

P2093

Sinéad M Ryan

http://www.w3.org/2001/XMLSchema#string

Xuexuan Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Peptide and protein PEGylation: a review of problems and solutions

Pegaspargase: a review of clinical studies

PEGylation, successful approach to drug delivery

Pharmacokinetic and biodistribution properties of poly(ethylene glycol)-protein conjugates.

The AIR inhaled insulin system: system components and pharmacokinetic/glucodynamic data.

PEG-modified protamine with improved pharmacological/pharmaceutical properties as a potential protamine substitute: synthesis and in vitro evaluation.

Synthesis of novel polyampholyte comb-type copolymers consisting of a poly(L-lysine) backbone and hyaluronic acid side chains for a DNA carrier.

Design and synthesis of N-maleimido-functionalized hydrophilic polymers via copper-mediated living radical polymerization: a suitable alternative to PEGylation chemistry.

Pegaptanib sodium for the treatment of neovascular age-related macular degeneration.

A highly stable polyethylene glycol-conjugated human single-chain antibody neutralizing granulocyte-macrophage colony stimulating factor at low nanomolar concentration.

P304

371-83

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/17425247.5.4.371

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

David J. Brayden

David M. Haddleton

Giuseppe Mantovani

P577

2008-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5427188

http://www.w3.org/2001/XMLSchema#string

P698

18426380

http://www.w3.org/2001/XMLSchema#string